Bone Biologics Shareholders Approve Reverse Split and 20% Warrant Issuance
BBLG sits 16% above its 52-week low of $0.428.
Summary
Bone Biologics shareholders approved a reverse stock split (up to 1-for-10) and the issuance of shares underlying warrants equal to or exceeding 20% of outstanding common stock at the September 28 annual meeting.
Key Events · Corporate Governance and Compliance · BBLG
-
Reverse Stock Split Approved
Shareholders approved a reverse split in a range of 1-for-2 to 1-for-10 at the board's discretion, with 806,603 votes for and 137,720 against. This is a direct response to Nasdaq's September 16 delisting notice for failing the $1 minimum bid price requirement.
-
Warrant Share Issuance Approved
Shareholders approved the potential issuance of shares underlying warrants equal to or exceeding 20% of outstanding common stock, with 147,340 votes for and 42,233 against. This clears the way for full exercise of warrants from the July 2026 private placement.
-
Directors and Auditor Ratified
All four director nominees were elected, executive compensation was approved on an advisory basis, and Weinberg & Company, P.A. was ratified as independent auditor for fiscal year 2026.
-
Nasdaq Compliance Pressure
The reverse split approval comes 12 days after Nasdaq formally notified the company it no longer meets the $1 minimum bid price requirement, giving the company a limited window to regain compliance.
Analysis · BBLG · Industrial Applications And Services
Shareholders approved a reverse stock split of up to 1-for-10 and the potential issuance of shares underlying warrants equal to or exceeding 20% of outstanding common stock. The reverse split is a direct response to Nasdaq's September 16 delisting notice for failing the $1 minimum bid price requirement. The warrant issuance approval clears the way for the full exercise of warrants from the July 2026 private placement, which could add significant dilution. Both approvals were expected but are now binding, giving the board discretion to execute the split and the company the ability to issue the warrant shares.
How filings like this one have moved
In the 30 days to Oct 15, 2026, 37.1% of the 989 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.64%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, BBLG was trading at $0.50 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.4M. The 52-week trading range was $0.43 to $2.89. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.